Hematology/Oncology News and Events
Drs. Katie Berlacher and Sarah Gaffen named inaugural recipients of the Magaret Ragni Award for Advancement of Women in Medicine and Science
The award recognizes Drs. Berlacher’s and Gaffen’s commitment to research, inclusivity, and mentorship as women leaders in the Department of Medicine
Dr. Wei Du publishes new findings on the role of AREG in compromising hematopoietic stem cell maintenance during DNA damage in “Blood”
Congratulations to Dr. Wei Du and her team on their new publication entitled: “LepR+ niche cell-derived AREG compromises hematopoietic stem cell maintenance under conditions of DNA repair deficiency and aging”, published recently in the journal Blood.
Dr. Benjamin Nacev receives Damon Runyon Clinical Investigator Award
Congratulations to Dr. Benjamin Nacev for receiving the Damon Runyon Clinical Investigator Award for his research focused on “Understanding and targeting chromatin reorganization in ATRX deficient sarcomas”.
ASCO 2023
The Division of Hem Onc was again strongly represented at this year’s ASCO meeting with many residents, fellows and faculty attending and presenting their recent findings. Congratulations to Dr. Manisha Bhattacharya for receiving the competitive ASCO Young Investigator Award and to Division chief Dr. Taofeek Owonikoko who has been named ASCO treasurer for 2023-24.
Dr. Samit Ghosh awarded new NIH-NIDDK R01 for his work on chronic kidney disease associated with sickle cell disorders
Dr. Samit Ghosh has received a new R01 from NIDDK titled “Renal endothelium and the development of chronic kidney disease in sickle cell disorders”. With this funding Dr. Ghosh will study Progressive chronic kidney disease (CKD) associated with intravascular hemolysis...
Spring 2023 Research Highlights
Highlighted Publications Graft-versus-host disease is locally maintained in target tissues by resident progenitor-like T cells. In allogeneic hematopoietic stem cell transplantation, donor αβ T cells attack recipient tissues, causing graft-versus-host disease (GVHD),...
Drs. Davar and Zarour discuss their ongoing work on fecal microbiota transplants to improve response to immunotherapy
Dr. Hassane Zarour and Dr. Diwakar Davar are featured on UPMC Physician Journal discussing their ground breaking clinical trial published in Science and ongoing work on the benefits of fecal microbiota transplants to overcome anti-PD-1 therapy resistance and improve...
Groundbreaking new study by Dr. Warren Shlomchik et al provides new avenues for treatment in graft-versus-host disease
The paper, published in Immunity, showed that GVHD is maintained by donor T cells that seed those tissues soon after transplant and not by the continual recruitment of T cells from the blood as previously thought.
PACCM and Hematology/Oncology faculty collaborate to identify link between telomere mutations and melonama
In a recent Science paper, Drs. Jonathan Alder, John Kirkwood and others describe TPP1 mutations leading to telomere lengthening and the promotion of melanoma cells.
Division strongly represented at annual ASH meeting in New Orleans
Division of Hematology Oncology residents, trainees and faculty are strongly represented at this year's annual meeting of the American Society of Hematology (ASH) held in New Orleans, Louisiana, December 10-13, 2022, presenting their translational, clinical and basic...
Visit the UPMC Hillman Cancer Center events calendar for a listing of cancer related events and seminars.
Contact Us
Division of Hematology/Oncology
Administrative/Academic Offices
UPMC Cancer Pavilion
5150 Centre Avenue, 5th floor
Pittsburgh, PA 15232
412-648-6575 | Email Us
UPMC Hillman Cancer Center
Outpatient Services
5115 Centre Avenue
Pittsburgh, PA 15232
412-692-4724